Oct Therapies And Research Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
- Paid Up Capital ₹ 6.09 M
- Company Age 11 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 32.77%
- Profit Growth -429.76%
- Ebitda -441.54%
- Net Worth 544.22%
- Total Assets 36.47%
About Oct Therapies And Research
Oct Therapies And Research Private Limited (OTARPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 June 2013 and has a history of 11 years and eight months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 6.09 M, as per Ministry of Corporate Affairs (MCA) records.
Caroline Mathen and Mathen Mathew serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24100MH2013PTC244048
-
Company No.
244048
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Jun 2013
-
Date of AGM
23 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Oct Therapies And Research?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mathen Mathew
|
Director | 05-Jun-2013 | Current |
|
Caroline Mathen
|
Director | 05-Jun-2013 | Current |
Financial Performance of Oct Therapies And Research.
Oct Therapies And Research Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 32.77% increase. The company also saw a substantial fall in profitability, with a 429.76% decrease in profit. The company's net worth Soared by an impressive increase of 544.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oct Therapies And Research?
In 2023, Oct Therapies And Research had a promoter holding of 69.99% and a public holding of 30.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Oct Therapies And Research?
Unlock and access historical data on people associated with Oct Therapies And Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oct Therapies And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oct Therapies And Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.